Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy: A psychological perspective.
作者信息
Polacek Laura C, Nelson Christian J
机构信息
Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Psychology, Fordham University, Bronx, New York.
出版信息
Cancer. 2019 Apr 1;125(7):1027-1029. doi: 10.1002/cncr.31980. Epub 2019 Feb 12.
Abstract
摘要
相似文献
1
Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy: A psychological perspective.接受根治性放射治疗的前列腺癌男性患者的雄激素剥夺治疗与抑郁：心理学视角
Cancer. 2019 Apr 1;125(7):1027-1029. doi: 10.1002/cncr.31980. Epub 2019 Feb 12.
2
Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.雄激素剥夺疗法与接受根治性放射治疗的前列腺癌男性患者的抑郁。
Cancer. 2019 Apr 1;125(7):1070-1080. doi: 10.1002/cncr.31982. Epub 2019 Feb 12.
3
Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.对于接受加速分割放疗方案治疗的预后不良前列腺癌患者，短期雄激素剥夺治疗并无益处。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31. doi: 10.1016/j.ijrobp.2004.12.053.
4
Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy.根治性前列腺切除术后前列腺癌复发的男性接受雄激素剥夺治疗的结果和预后因素。
J Urol. 2018 Nov;200(5):1075-1081. doi: 10.1016/j.juro.2018.04.070. Epub 2018 Apr 27.
5
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.死亡率与雄激素剥夺疗法作为临床局限性前列腺癌初始治疗后生化复发的挽救性治疗手段
J Urol. 2017 Jun;197(6):1448-1454. doi: 10.1016/j.juro.2016.12.086. Epub 2016 Dec 19.
6
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.雄激素剥夺治疗时机对 PSA 升高的前列腺癌患者的影响（TROG 03.06 和 VCOG PR 01-03 [TOAD]）：一项随机、多中心、非盲、3 期临床试验。
Lancet Oncol. 2016 Jun;17(6):727-737. doi: 10.1016/S1470-2045(16)00107-8. Epub 2016 May 4.
7
Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE.雄激素剥夺疗法联合外照射治疗前列腺癌：来自CaPSURE的结果。
J Urol. 2005 Nov;174(5):1802-7. doi: 10.1097/01.ju.0000177089.93728.20.
8
Androgen deprivation therapy use and risk of death in men treated with high-dose radiation for intermediate-risk prostate cancer.
Cancer. 2016 Aug 1;122(15):2296-8. doi: 10.1002/cncr.30048. Epub 2016 May 18.
9
Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.抑郁症状被发现是雄激素剥夺疗法在老年前列腺癌患者中的潜在不良反应：一项 15 个月的前瞻性观察研究。
Psychooncology. 2017 Dec;26(12):2238-2244. doi: 10.1002/pon.4453. Epub 2017 May 31.
10
Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.雄激素剥夺疗法对前列腺癌放射治疗后枸橼酸西地那非反应的影响分析。
J Urol. 2007 Dec;178(6):2521-5. doi: 10.1016/j.juro.2007.08.007. Epub 2007 Oct 15.
引用本文的文献
1
Risk factors and risk-stratification model of biochemical failure in patients with positive surgical margin after robot-assisted radical prostatectomy.机器人辅助根治性前列腺切除术后手术切缘阳性患者生化复发的危险因素及风险分层模型
J Robot Surg. 2025 Jun 4;19(1):261. doi: 10.1007/s11701-025-02426-x.
本文引用的文献
1
Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.雄激素剥夺疗法与接受根治性放射治疗的前列腺癌男性患者的抑郁。
Cancer. 2019 Apr 1;125(7):1070-1080. doi: 10.1002/cncr.31982. Epub 2019 Feb 12.
2
Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis.雄激素剥夺疗法与前列腺癌治疗中抑郁症的关联：一项系统评价与荟萃分析。
Urol Oncol. 2017 Nov;35(11):664.e1-664.e9. doi: 10.1016/j.urolonc.2017.07.016. Epub 2017 Aug 10.
3
Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer.雄激素剥夺疗法对晚期前列腺癌男性患者的认知影响。
Urology. 2017 May;103:167-172. doi: 10.1016/j.urology.2016.12.060. Epub 2017 Feb 7.
4
Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer.雄激素剥夺疗法与局限性前列腺癌患者抑郁的关联
J Clin Oncol. 2016 Jun 1;34(16):1905-12. doi: 10.1200/JCO.2015.64.1969. Epub 2016 Apr 11.
5
Towards a new conceptualization of depression in older adult cancer patients: a review of the literature.老年癌症患者抑郁症的新概念化：文献综述
Aging Ment Health. 2016 Dec;20(12):1230-1242. doi: 10.1080/13607863.2015.1078278. Epub 2015 Aug 27.
6
Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation.成人癌症患者焦虑和抑郁症状的筛查、评估和照护：美国临床肿瘤学会指南的改编。
J Clin Oncol. 2014 May 20;32(15):1605-19. doi: 10.1200/JCO.2013.52.4611. Epub 2014 Apr 14.
7
Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments.癌症患者中抑郁症的患病率：诊断访谈和自我报告工具的荟萃分析。
Psychooncology. 2014 Feb;23(2):121-30. doi: 10.1002/pon.3409. Epub 2013 Sep 16.
8
The burden of depression in prostate cancer.前列腺癌中的抑郁负担。
Psychooncology. 2012 Dec;21(12):1338-45. doi: 10.1002/pon.2032. Epub 2011 Aug 12.
9
Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats.去势和激素替代对成年雄性大鼠前额叶皮层和纹状体中单胺氧化酶和儿茶酚-O-甲基转移酶活性具有区域和酶同工型特异性的影响。
Neuroscience. 2010 Feb 3;165(3):850-62. doi: 10.1016/j.neuroscience.2009.11.013. Epub 2009 Nov 10.
10
Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria.癌症患者抑郁严重程度的症状指标：DSM-IV标准与替代诊断标准的比较
Gen Hosp Psychiatry. 2009 May-Jun;31(3):225-32. doi: 10.1016/j.genhosppsych.2008.12.004. Epub 2009 Feb 1.
Zotero 插件